ArticleBMC public health2026
Insufficient mpox knowledge among public health professionals involved in infectious disease prevention and control in China: a large-scale online cross-sectional survey.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe World Health Organization has declared mpox a Public Health Emergency of International Concern twice. In China, public health professionals (PHPs) involved in infectious disease prevention and control are responsible for mpox control, case reporting, and health communications during outbreaks. This study aimed to assess mpox knowledge and factors associated with sufficient mpox knowledge among PHPs in China.
methodsThis study analyzed PHPs involved in infectious disease prevention and control from a large-scale online cross-sectional survey of healthcare workers conducted through a nationwide platform. An e-questionnaire was used to collect data on demographic and institutional characteristics, attention to mpox, mpox information sources, training history and 37 mpox knowledge items covering etiology, clinical features, transmission, and prevention. Univariable and multivariable logistic regression analyses were performed to identify factors associated with sufficient mpox knowledge.
resultsA total of 1,601 PHPs from 28 of 31 provincial-level regions in China completed the survey, and 1,568 valid responses were included. Among the 1,568 PHPs, 91.3% (1,432/1,568) were aware of mpox, and 61.7% (967/1,568, 95% CI: 59.3%-64.1%) had sufficient mpox knowledge. 44.6% (95% CI: 42.1%-47.0%), 74.2% (95%CI: 72.1%-76.4%) and 47.0% (95% CI: 44.5%-49.5%) PHPs aware of mpox had sufficient knowledge regarding etiology, clinical features and transmission and prevention, respectively. Multivariable logistic regression analysis showed that the associated factors with sufficient mpox knowledge included gender (female: OR = 1.34, 95% CI: 1.03-1.74), professional title (intermediate: OR = 1.85, 95% CI: 1.40-2.45, senior: OR = 2.05, 95% CI: 1.44-2.91), institution (CDC: OR = 2.07, 95% CI: 1.60-2.67), attention toward mpox (occasional: OR = 2.59, 95% CI: 1.72-3.90; daily/frequent: OR = 3.70, 95% CI: 2.39-5.73), mpox information sources (two sources: OR = 1.51, 95% CI: 1.14-2.00; three or more sources: OR = 1.77, 95% CI: 1.31-2.39), and training (OR = 2.44, 95% CI: 1.89-3.15).
conclusionThis study found insufficient mpox knowledge among the surveyed PHPs involved in infectious disease prevention and control across multiple regions of China, especially among males, those with junior professional titles, limited information access, low attention to mpox, no prior training, and hospital-based staff. Targeted training, continuing education, and multi-channel information dissemination should be strengthened to support mpox preparedness among frontline PHPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.